Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenluo Yuchun pills is a Traditional Chinese Medicine (TCM) formulation developed by Shanghai Taikuntang Hospital of TCM. It is specifically designed for the treatment of polycystic ovary syndrome (PCOS) in patients characterized by the TCM syndrome of kidney-yin deficiency and phlegm-blood stasis. The formulation is typically used in clinical trials to evaluate its efficacy in improving menstrual regularity, ovulation, and metabolic parameters compared to standard Western treatments like metformin and oral contraceptives. As a TCM product, its mechanism involves a multi-target approach aimed at tonifying the kidney, resolving phlegm, and removing blood stasis to restore hormonal balance and improve reproductive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenluo Yuchun pills.